2018
DOI: 10.3389/fcell.2018.00043
|View full text |Cite
|
Sign up to set email alerts
|

Moving the Cellular Peptidome by Transporters

Abstract: Living matter is defined by metastability, implying a tightly balanced synthesis and turnover of cellular components. The first step of eukaryotic protein degradation via the ubiquitin-proteasome system (UPS) leads to peptides, which are subsequently degraded to single amino acids by an armada of proteases. A small fraction of peptides, however, escapes further cytosolic destruction and is transported by ATP-binding cassette (ABC) transporters into the endoplasmic reticulum (ER) and lysosomes. The ER-resident … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(12 citation statements)
references
References 119 publications
0
11
0
Order By: Relevance
“…The response to immune checkpoint inhibitors has been shown to correlate with the mutational burden of the tumor cell [10,11] and the number of mutations in a typical ccRCC is several orders of magnitude less than that observed in melanoma or NSCLC [12], suggesting that ccRCC should have limited expression of novel tumor-specific antigens and at best, a modest immune cell infiltrate. The molecular basis for the robust immune cell infiltration and response to immunotherapy observed with RCC is not entirely clear but may be due to the upregulation of genes associated with antigen processing and peptide loading onto HLA Class I molecules such as TAP1 and TAP2 [13] or antigen presentation such as HLA-A, B, and C, and β 2 -microglobulin. Senbabaoglu et al recently compared the expression of these genes in various tumors with that of adjoining normal tissue and observed the greatest variance between the paired tissues in ccRCC tumors [4].…”
Section: Cellular Composition Of the Rcc Microenvironment Tumor-infilmentioning
confidence: 99%
“…The response to immune checkpoint inhibitors has been shown to correlate with the mutational burden of the tumor cell [10,11] and the number of mutations in a typical ccRCC is several orders of magnitude less than that observed in melanoma or NSCLC [12], suggesting that ccRCC should have limited expression of novel tumor-specific antigens and at best, a modest immune cell infiltrate. The molecular basis for the robust immune cell infiltration and response to immunotherapy observed with RCC is not entirely clear but may be due to the upregulation of genes associated with antigen processing and peptide loading onto HLA Class I molecules such as TAP1 and TAP2 [13] or antigen presentation such as HLA-A, B, and C, and β 2 -microglobulin. Senbabaoglu et al recently compared the expression of these genes in various tumors with that of adjoining normal tissue and observed the greatest variance between the paired tissues in ccRCC tumors [4].…”
Section: Cellular Composition Of the Rcc Microenvironment Tumor-infilmentioning
confidence: 99%
“…The translocation of peptides and proteins across the membrane bilayer is a fundamental process in all three domains of life (Rapoport et al, 2017). Bacteria secrete peptides and proteins for survival and adaptation to different ecological niches, to mediate intercellular signaling, and to deter or kill other microorganisms that may compete for limited resources (Abele and Tampé, 2018). Transport of intracellularly produced peptides in bacteria is mediated by ABC transporters, which utilize the energy of ATP binding and hydrolysis to translocate substrates across the bilayer (ter Beek et al, 2014; Beis, 2015).…”
Section: Introductionmentioning
confidence: 99%
“…Peptides from such proteins might be exported into the apoplast during fusion of vacuolar vesicles with the plasma membrane. Also, peptides can be transported into the extracellular space by peptide transporters …”
Section: Discussionmentioning
confidence: 99%